Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
22 October 2013
CPhI PREVIEW
About CPhi
Pharma and Exhibitor News
PharmTech News
Linked In
 

It’s Show Time: October 22

Key players in the bio/pharmaceutical market have gathered in Frankfurt for CPhI Worldwide. Read about the latest developments and preview the finalists for the 2013 CPhI Awards.

 
Unlocking the True Potential of Antibody Drug Conjugates
The success of Adcetris and Kadcyla is paving the way for more antibody drug conjugates to enter the market, especially in the treatment of solid tumors. More...
 
From Blockbusters to Niche Medicines
Part II of CPhI industry report reveals some key trends across the pharmaceutical industry, such as a shift away from the blockbuster business model, increasing collaboration between industry and academia, more information sharing within companies and better use of data. More...
 
HPAPI Manufacturing
Experts from Patheon provide insights on the production and handling of HPAPIs, steps to avoid cross contamination, and technology advances in HPAPI manufacturing. More...
 
Cambridge Major Laboratories Discusses Strategy on its Merger with AAIPharma Services
Brian Scanlan, CEO and president of Cambridge Major Laboratories, discusses the rationale behind the company's merger with AAIPharma Services. More...
 
CPhI Announces Finalists for Pharma Awards
Winners for the 2013 CPhI Pharma Awards, which recognize pharmaceutical innovation, will be awarded on later today, Tuesday Oct. 22. More...
 
What do you think are the most significant factors influencing demand for contract manufacturing of APIs and intermediates?
Join the discussion on LinkedIn. More...
 
 
Pharma Ingredients Topics
Implications for APIs in the European Falsified Medicines Directive
The Active Pharmaceuticals Ingredient Committee and the European Fine Chemicals Group, both sector groups of the European Chemical Industry Council, offer perspectives on the European Falsified Medicines Directive. More...
 
Gaining Insights on Contract Chemical API Manufacturing:  An Industry Roundtable
Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing. More...
 
The Importance of Characterization in Biosimilars
Industry experts discuss the requirements and challenges involved in getting a biosimilar product from bench to launch. More...
 
CPhI Twitter News
CPhI Global Pharma
Choose from 100+ free seminars during CPhI including speakers corners on ingredients, contract services, packaging. More...
 
CPhI Global Pharma
Download the CPhI mobile app before you get to the event - plan your agenda w/exhibitor list and session schedules. More...
 
PharmTech
Meet the PharmTech editors at CPhI. Visit us at stand 31H34.
 

Product Profile
Greiner Bio-One GmbH
Visit us at CPhI, Hall 4.1, Booth 41H09
Greiner Bio-One is specialised in the development, production and distribution of plastic laboratory products. The company is a technology partner for universities, hospitals, research institutes and the diagnostic, pharmaceutical and biotechnology industries as well. Read more.
Powder Systems Ltd (PSL)
Visit us at CPhI,  Hall 4.1 Stand J50
The GFD® is changing the filtration and drying process in laboratories worldwide. The GFD technology combines filtration, cake washing and drying all in one glass vessel and is suitable for microsphere filtration. Read more.

Contact Us

Click here to contact editorial.

Click here to contact sales.